Articles From: AES Announces Strategic Partnership for its Business in the Dominican Republic to Aerie Pharmaceuticals Inc. Initiates Phase 3 Safety-Only Registration Trial in Canada of RhopressaTM in Patients with Glaucoma


The AES Corporation (NYSE: AES) announced today that it has, through one of its subsidiaries, entered into a strategic partnership with the Estrella-Linda Group (“Estrella-Linda”), an investor group based in the Dominican Republic.
Sign-up for AES Announces Strategic Partnership for its Business in the Dominican Republic investment picks
2014/9/3
PLYMOUTH MEETING, Pa.
Sign-up for Inovio to Present at Upcoming Investor Conferences investment picks
2014/9/3
In recognition of its innovation on behalf of patients, investments in product line development, and its rapidly escalating growth, Insys Therapeutics, Inc., of Chandler, Arizona, was named the 2014 Arizona Bioscience Company of the Year by the Arizona Bioindustry Association (AZBio). Insys Therapeutics, Inc. (NASDAQ: INSY) is a commercial-stage specialty pharmaceutical company based in Chandler, Arizona, that develops and commercializes innovative supportive care products.
Sign-up for Insys Therapeutics, Inc. Named Arizona Bioscience Company of the Year investment picks
LAVAL, Quebec, Sept.
Sign-up for Neptune to Present at Rodman & Renshaw Global Investment Conference investment picks
2014/9/3
National Co-op Challenge finalists announced Canada NewsWire Public voting to decide who shares $200,000 in prizes GUELPH, ON , Sept.
Sign-up for National Co-op Challenge finalists announced investment picks
My Passport® Wireless External Hard Drive Expands Storage for all Devices With No Need for Wires or Internet IRVINE, Calif.
Sign-up for New WD® Portable Storage Drive Wirelessly Connects To Smartphones, Tablets, Cameras And More investment picks
Huron Consulting Group Inc. (NASDAQ: HURN), a leading provider of business consulting services, today announced that James H.
Sign-up for Huron Consulting Group to Present at Deutsche Bank Technology Conference on September 10 investment picks
By Angela Johnson, MarketWatch NEW YORK (MarketWatch) -- These stocks are seeing notable moves early Wednesday: Gainers: Infinity Pharmaceuticals Inc.(INFI): The biotech company has a new collaboration with AbbVie Inc.(ABBV) to develop and commercialize Infinity's duvelisib, a treatment for blood cancers.
Sign-up for UPDATE: Infinity, Navistar climb; Toll Brothers falls investment picks
2014/9/3
Ryder System, Inc. (NYSE: R) Chairman and Chief Executive Officer Robert Sanchez will present a company update at the 7 th Annual Longbow Research Industrial Manufacturing & Technology Conference.
Sign-up for Ryder to Address Longbow Research Industrial Conference investment picks
2014/9/3
By Shelly Banjo Home Depot Inc. took steps to reassure customers through its website and social-media accounts about a potential data breach of credit and debit cards.
Sign-up for Home Depot Tries to Reassure Customers About Possible Data Breach investment picks
Enable Midstream Partners, LP (NYSE:ENBL) announced today its Board of Directors approved construction of an additional 200-million cubic feet per day (MMcf/d) of natural gas processing capacity that will be located near its Bradley Processing Plant to serve producers in the rich gas play called the South Central Oklahoma Oil Province (SCOOP). The Bradley Plant is located in Grady County in central Okla., is currently under construction to provide 200 MMcf/d of processing capacity, and is expected to be in service during the first quarter of 2015.
Sign-up for Enable Midstream Announces New Natural Gas Processing Plant Located in Prolific SCOOP Play investment picks
NEW BRUNSWICK, N.J. , Sept.
Sign-up for Johnson & Johnson to Participate in 2014 Morgan Stanley Health Care Conference investment picks
HUNTSVILLE, Texas, Aug.
Sign-up for Mitcham Industries Announces Fiscal 2015 Second Quarter Earnings Release And Conference Call Schedule investment picks
2014/9/3
By Shelly Banjo Home Depot Inc. took steps to reassure customers through its website and social-media accounts about a potential data breach of credit and debit cards.
Sign-up for Home Depot tries to reassure customers about possible data breach investment picks
Shares of Infinity Pharmaceuticals (INFI) soared 46% in premarket trade Wednesday, after the company said it would receive an upfront payment of $275 million from AbbVie (ABBV) as part of a new collaboration to develop and commercialize Infinity's duvelisib, a treatment for blood cancers.
Sign-up for Infinity Pharmaceuticals shares soar after AbbVie collaboration investment picks
Truck maker Navistar International Inc. (NAV) said Wednesday it had a net loss of $2 million, or 2 cents a share, in its third fiscal quarter ended July 31, after a loss of $247 million, or $3.06 a share, in the year-earlier period.
Sign-up for Navistar loss narrows, but revenues remain flat in Q3 investment picks
Manchester United plc (NYSE: MANU) (the “Company”), one of the most popular and successful sports teams in the world, playing one of the most popular spectator sports on Earth, today announced that it will report fourth quarter and fiscal 2014 full year results on Wednesday, 10 September 2014, at approximately 7:00 a.m. ET.
Sign-up for Manchester United plc Announces Fourth Quarter and Fiscal 2014 Earnings Report Date investment picks
Zix Corporation (ZixCorp), (NASDAQ: ZIXI), a leader in email data protection, announces that DCP has switched its email encryption solution from Cisco’s IronPort Encryption Appliance (IEA) to Zix ® Email Encryption in a new three-year contract.
Sign-up for DCP Selects Zix Email Encryption to Replace Cisco investment picks
Meridian Bioscience Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced it has signed a new agreement with Premier, Inc. to offer the complete illumi gene ® molecular menu of tests to its members.
Sign-up for Meridian Bioscience Signs Agreement with Premier, Inc. to Offer Its Hospitals Molecular Diagnostic Tests and Instruments for C. difficile, Group B Streptococcus, Group A Streptococcus, Bordetella pertussis, and Mycoplasma pneumoniae investment picks
2014/9/3
Gabelli & Company will host its 20 th Annual Aircraft Supplier Conference on September 9 in New York City.
Sign-up for Gabelli & Company’s 20th Annual Aircraft Supplier Conference investment picks
Recognition Reiterates the Increasing Need for Boardroom Communications WASHINGTON , Sept.
Sign-up for The National Association of Corporate Directors Names Corporate Governance Communications Expert Elizabeth Saunders to the 'Directorship 100': Governance Professionals and Institutions List for a Second Consecutive Year investment picks
Dun & Bradstreet (NYSE:DNB), the world’s leading provider of commercial business intelligence, today announced the appointment of Curtis Brown to the role of Chief Information Officer (CIO), reporting to Chief Operating Officer Josh Peirez, effective immediately.
Sign-up for Dun & Bradstreet Names Technology Veteran Curtis Brown New Chief Information Officer investment picks
Sweden is latest country to grant marketing authorization ATLANTA , Sept.
Sign-up for Alimera Sciences' ILUVIEN® Receives Tenth National Marketing Authorization For The Treatment Of Chronic Diabetic Macular Edema investment picks
GRAPEVINE, Texas , Sept.
Sign-up for United Development Funding IV Finances Acquisition of Scott Felder Homes investment picks
- Akamai CEO Dr.
Sign-up for Akamai at IBC 2014: Defining the Next-Generation Content Delivery Network investment picks
Local Corporation (NASDAQ: LOCM), a leading local search and advertising technology company, today announced that it has reached a favorable settlement agreement in its patent infringement action with Fry’s Electronics, Inc. The terms of the settlement are confidential.
Sign-up for Local Corporation Reaches Favorable Settlement in Patent Infringement Litigation investment picks
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that on August 29, dosing commenced of the first patients enrolled in the Company’s Phase 3 registration trial in Canada of Rhopressa TM , a novel once-daily, triple-action eye drop being tested for its ability to lower intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.
Sign-up for Aerie Pharmaceuticals Inc. Initiates Phase 3 Safety-Only Registration Trial in Canada of RhopressaTM in Patients with Glaucoma investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: AES Announces Strategic Partnership for its Business in the Dominican Republic to Aerie Pharmaceuticals Inc. Initiates Phase 3 Safety-Only Registration Trial in Canada of RhopressaTM in Patients with Glaucoma
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices